Atlantic Pharma demonstrated its commitment to the respiratory field with its support as a Launch Partner for the inaugural Respiratory Show in Birmingham recently.
Lung disease is the UK’s third highest killer, but unlike other major disease areas, mortality rates have not decreased in over a decade. The NHS Long Term Plan now highlights respiratory disease as a clinical priority area, giving new focus to improving delivery of care.
With over 1,000 delegates, the show attracted customers from every part of respiratory medicine across both primary and secondary care.
The show was co-located with Best Practice and Best Practice in Nursing which is the UK’s largest general practice event, attended by over 6,000 decision makers and key influencers.
The show offered a stimulating conference programme delivered by a range of respiratory experts and included a number of hands-on courses for delegates to gain experience with the latest techniques, and expert talks on a number of key topics.
As a Launch Partner for the show, Atlantic also supported one of these lectures in the Respiratory Clinical Theatre.
Entitled “Mucolytics – Changing Old Habits”, Lindsey Clayton – Medicines Safety Officer for Wakefield CCG -delivered a thought-provoking talk on the benefits of changing their CCG policy to favour NACSYS® (acetylcysteine 600mg effervescent tablets) when prescribing mucolytics for appropriate patients.
A mixed audience of around 100 delegates listened to Lindsey cover the benefits to patients and prescribers, and the cost savings consequently made available to the local healthcare economy in Wakefield.
Respiratory conditions are the most common reason for a general practice consultation and account for more than 24 million GP visits annually.
GPs, nurses and clinical pharmacists are at the frontline of care in this field, and Atlantic Pharma were proud to support this important educational event.
Company values of Integrity, Partnership, and Reliability help to ensure that Atlantic Pharma is focused on reliably delivering a growing number of high-quality products which make a difference to patients’ lives, but at responsible prices which can help to save the Health Service valuable resources.
Based in Milton Keynes, the management team are constantly liaising with senior NHS decision-makers to try and better understand current prescribing challenges, with a view to sourcing and delivering solutions which provide better value.
Please use the Contact Us page if you would like any further information relating to this news item or would like a member of the team to get in touch.